Ferzsons Laboratories Considers Acquiring Barrett Hodgson Pakistan

Ferzsons Laboratories Limited (PSX: FEROZ) announced on Monday that its Board of Directors has authorized the company to proceed with due diligence for a potential acquisition of Barrett Hodgson Pakistan (Pvt.) Limited. The move is part of a consortium initiative involving leading business groups in Pakistan. The decision was taken during an emergent board meeting held on May 17, 2025, where the board reviewed a proposal submitted by the company’s Investment Committee. The board granted authority to the Chief Executive Officer and Chief Financial Officer to lead the due diligence process, appoint advisors, and handle all matters related to the potential acquisition. This includes signing relevant documents and providing bid security and other necessary financial commitments. Ferzsons clarified that any final decision regarding the purchase price and equity investment will be subject to the results of the due diligence and receipt of applicable approvals.